Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
Applied Health Economics and Health Policy|March 28, 2022
Cost-Effectiveness of Once-Weekly Semaglutide 1 mg versus Canagliflozin 300 mg in Patients with Type 2 Diabetes Mellitus in a Canadian SettingSara Stafford, Peter G Bech, Adam Fridhammar, et al.
Brain Research|March 3, 2007
Localization and expression of substance P in transgenic mice overexpressing human APP751 with the London (V717I) and Swedish (K670M/N671L) mutationsMichael Willis, Birgit Hutter-Paier, Georg Wietzorrek, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|December 2, 2020
Cost-Effectiveness of Canagliflozin Added to Standard of Care for Treating Diabetic Kidney Disease (DKD) in Patients with Type 2 Diabetes Mellitus (T2DM) in England: Estimates Using the CREDEM-DKD ModelMichael Willis, Andreas Nilsson, Klas Kellerborg, et al.
Science Advances|February 1, 2021
Peer review and gender bias: A study on 145 scholarly journalsFlaminio Squazzoni, Giangiacomo Bravo, Mike Farjam, et al.
European Journal of Nutrition|May 8, 2009
Adipocyte fatty acid binding protein during refeeding of female patients with anorexia nervosaJulia Engl, Alexander Tschoner, Michael Willis, et al.
Journal of Alzheimer'S Disease : JAD|April 24, 2010
L-type calcium channel CaV 1.2 in transgenic mice overexpressing human AbetaPP751 with the London (V717I) and Swedish (K670M/N671L) mutationsMichael Willis, Walter A Kaufmann, Georg Wietzorrek, et al.
Brain Research|February 26, 2008
Down-regulation of BK channel expression in the pilocarpine model of temporal lobe epilepsyLuis F Pacheco Otalora, Eder F Hernandez, Massoud F Arshadmansab, et al.
Journal of Alzheimer'S Disease : JAD|April 1, 2008
Chromogranin B and Secretogranin II in transgenic mice overexpressing human APP751 with the London (V717I) and Swedish (K670M/N671L) mutations and in Alzheimer patientsMichael Willis, Manuela Prokesch, Birgit Hutter-Paier, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 24, 2019
Accelerating changes in ice mass within Greenland, and the ice sheet's sensitivity to atmospheric forcingMichael Bevis, Christopher Harig, Shfaqat A Khan, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|July 10, 2024
Examining the Impact of Structural Uncertainty Across 10 Type 2 Diabetes Models: Results From the 2022 Mount Hood ChallengeJames Altunkaya, Xinyu Li, Amanda Adler, et al.
Pageof 6